|
Journal: Pharmaceutics (ISSN 1999-4923, IF 3.746)
Special Issue Name: Computational Drug Repurposing
Special Issue Link: https://www.mdpi.com/si/pharmaceutics/computational_drug_repurposing
Deadline for manuscript submissions: 31 May 2019
Instructions for authors: https://www.mdpi.com/journal/pharmaceutics/instructions
Please submit via: http://susy.mdpi.com
Special Issue Editors:
Prof. Dr. Ram Samudrala
Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA
Dr. Zackary Falls
Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA
Message from the Guest Editors:
Dear Colleagues,
Computational drug repurposing, i.e., finding new treatments for diseases using FDA approved drugs via computational methods, is one alternative method for increasing the efficacy of pharmaceutical research. Using modern computational tools to narrow the search for efficacious drugs from a pool of drugs greatly decreases cost. Furthermore, since all of the drugs being considered are FDA-approved, their toxicity and side effects profile are known, and the time from bench-to-bedside for a new indication is reduced as they have already been subjected to clinical trials.
Though many different approaches are being taken for drug repurposing, there has been no effort to assemble a comprehensive collection of knowledge of this field, specifically focused on computational methods, to have as a reference for novices and experts alike. In this Special Issue of Pharmaceutics, an understanding of how state-of-the-art computational drug repurposing methods make the drug-discovery process more efficient, as well as the juxtaposition of drug repurposing and drugdesign methods, will be comprehensively explored.
Prof. Dr. Ram Samudrala
Dr. Zackary Falls
Guest Editors
|
